Trial intelligence / Profile preview

Tacrolimus/Sirolimus/Prednisone vs Tacrolimus/Azathioprine/Prednisone in Lung Transplantation

NCT00321906Phase 4Completed

Sponsor
University of Chicago
Start
Apr 2002
Primary completion
Aug 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of sirolimus in graft rejection, delayed graft function (DGF), sponsored by University of Chicago. Started Apr 2002; status: completed.

02

Drugs

sirolimus
03

Conditions

graft rejectiondelayed graft function (DGF)

Beyond the preview

Go deeper on NCT00321906.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00321906.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call